EGRP-Supported Epidemiology Consortia

Ovarian Cancer


Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)

Since 2009
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
ENIGMA Liaison:

Gabriel Lai, Ph.D.

Lead Investigator:

David Goldgar, Ph.D.
University of Utah

Ovarian Cancer Association Consortium (OCAC)

Since 2005
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
OCAC Liaison:

Gabriel Lai, Ph.D.

Lead Investigator:

Andrew Berchuck, M.D.
Duke University Comprehensive Cancer Center

Ovarian Cancer Cohort Consortium (OC3)

Since 2009
NIH Contacts

EGRP/NCI:

OC3 Liaison and Scientific Consortia Coordinator:
Gabriel Lai, Ph.D.

DCEG/NCI:

Nicolas Wentzensen, M.D., Ph.D.

Lead Investigators:

Shelley Tworoger, Ph.D.
Harvard University School of Public Health

Alan Arslan, M.D.
New York University

Ovarian Cancer in Women of African Ancestry (OCWAA)

Since 2013

Pacific Ovarian Cancer Research Consortium (POCRC)

Since 1999
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
POCRC Liaison:

Gabriel Lai, Ph.D.

Lead Investigator:

Nicole Urban, Ph.D.
University of Washington School of Public Health

Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)

NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
PROSE Liaison:

Gabriel Lai, Ph.D.

Lead Investigators:

Timothy Rebbeck, Ph.D.
University of Pennsylvania

Key to Acronyms Used in Tables

  • EGRP - Epidemiology and Genomics Research Program
  • CDC - Centers for Disease Control and Prevention
  • DCB - Division of Cancer Biology
  • DCEG - Division of Cancer Epidemiology and Genetics
  • NCI - National Cancer Institute
  • NHGRI - National Human Genome Research Institute
  • NIEHS - National Institute of Environmental Health Sciences
  • NIGMS - National Institute of General Medical Sciences
  • NIH - National Institutes of Health
  • OCS - Office of Cancer Survivorship
  • OD - Office of the Director

Return to Top